High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis.
S KurnoolN H NguyenJ ProudfootParambir S DulaiB S BolandN Vande CasteeleE EvansE L GrunvaldA ZarrinparWilliam J SandbornSiddharth SinghPublished in: Alimentary pharmacology & therapeutics (2018)
BMI is independently associated with increased risk of treatment failure in biologic-treated patients with UC, independent of dosing regimen.